LONDON (Reuters) - The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness.
from Reuters: Science News http://ift.tt/1Fy9LxA
via IFTTT
No comments:
Post a Comment